Atezolizumab-bevacizumab combo tops sunitinib as first-line therapy for RCCFebruary 7, 2018Renal Cell CarcinomaGenitourinary Cancer
Retroperitoneal lymphadenectomy did not impact OS and DFS for high risk, nonmetastatic renal cell carcinomaJanuary 29, 2018Renal Cell Carcinoma
OS similar among mRCC patients enrolled in clinical trials across different geographic regionsJanuary 17, 2018Renal Cell CarcinomaGenitourinary Cancer
Phase 1 study: Human IL-10 plus checkpoint blockade looks promising in RCC, NSCLCJanuary 11, 2018Renal Cell CarcinomaLung CancerImmunotherapy
In Brazil, few patients get second- and third-line treatment for metastatic RCCJanuary 9, 2018Renal Cell CarcinomaGenitourinary Cancer
Mutations linked to checkpoint inhibitor response in RCCJanuary 4, 2018Renal Cell CarcinomaGenitourinary Cancer
FDA approves cabozantinib for the frontline treatment of advanced RCCDecember 21, 2017Renal Cell Carcinoma
First-in-class glutaminase inhibitor combats anti-PD-1/PD-L1 resistanceDecember 2, 2017Immuno-oncologyMelanomaLung CancerRenal Cell Carcinoma
FDA approves sunitinib malate as adjuvant treatment for RCCNovember 17, 2017Renal Cell CarcinomaGenitourinary Cancer
Cancer patients with TKI-induced hypothyroidism had better survival ratesNovember 15, 2017Patient & Survivor CareGastroenterologyLeukemia, Myelodysplasia, TransplantationLung CancerRenal Cell CarcinomaHead & Neck/Thyroid CancersBreast Cancer
CheckMate 214: Updated results for RCC focus on PD-L1 expression, QOLNovember 13, 2017Renal Cell CarcinomaImmuno-oncology
Perioperative blood transfusion linked to worse outcomes in renal cell carcinomaNovember 5, 2017Renal Cell CarcinomaGenitourinary Cancer
High EZH2 expression a marker for death risk in RCCOctober 17, 2017Renal Cell CarcinomaGenitourinary Cancer
Checkmate 214: Upfront nivo/ipi bests TKI in advanced RCCSeptember 28, 2017Renal Cell CarcinomaImmunotherapyImmuno-oncology
